Selexipag and the pulmonary hypertension continuum.
2022
Micha T Maeder
Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.
UI
MeSH Term
Description
Entries
D006976
Hypertension, Pulmonary
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
Pulmonary Hypertension
D011719
Pyrazines
A heterocyclic aromatic organic compound with the chemical formula C4H4N2.
Pyrazine
D006333
Heart Failure
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.